483 Hikma Pharmaceuticals USA Oct 2013

483 Hikma Pharmaceuticals USA Oct 2013

Barbara Wilimczyk-Macri FDA$119.00 - Available Now

FDA investigators audited the Hikma Pharmaceuticals USA - Cherry Hill, NJ, United States facility and issued inspectional observations (via FDA 483) on 22 Oct 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Oct 2013
  • Location: Cherry Hill, United States
  • FEI: 2220525
Add To Cart